Back to Journals » Drug Design, Development and Therapy » Volume 6
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, Fingolimod will change therapeutic paradigm approach
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
18,147 | Dovepress* | 14,169+ | 2,911 | 17,080 | |
PubMed Central* | 3,978 | 1,625 | 5,603 | ||
Totals | 18,147 | 4,536 | 22,683 | ||
*Since 19 July 2012 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
11 | 0 | 0 | 0 | 2 | 9 |
View citations on PubMed Central and Google Scholar